Short-and long-term corneal vascular effects of tafluprost eye drops
D Hos, KR Koch, F Bock, RS Grajewski… - Graefe's Archive for …, 2013 - Springer
Background Prostaglandin analogs are first line therapy in the treatment of glaucoma, but
also display side effects during ocular inflammation. In this context, the potential side effects …
also display side effects during ocular inflammation. In this context, the potential side effects …
Recent patents on emerging therapeutics for the treatment of glaucoma, age related macular degeneration and uveitis
A Dutt Vadlapudi, A Patel, K Cholkar… - Recent Patents on …, 2012 - ingentaconnect.com
Advancements in the field and rising interest among pharmaceutical researchers have led to
the development of new molecules with enhanced therapeutic activity. Design of new drugs …
the development of new molecules with enhanced therapeutic activity. Design of new drugs …
[PDF][PDF] Beta-bloqueantes e asma
MB Coelho, MB Ferreira - Revista Portuguesa de Medicina Geral …, 2021 - scholar.archive.org
Introdução: Os doentes asmáticos têm por vezes outras patologias concomitantes para as
quais é necessário o uso de beta--bloqueantes. Tendo em conta que a terapêutica com …
quais é necessário o uso de beta--bloqueantes. Tendo em conta que a terapêutica com …
[PDF][PDF] Glaucoma: a primary care review with a focus on medication management
L Skorin, D Blanco, L Goemann - Consultant, 2017 - researchgate.net
Glaucoma can cause progressive, irreversible vision loss if it is not promptly and properly
diagnosed and treated. While the disease is typically managed by ophthalmology …
diagnosed and treated. While the disease is typically managed by ophthalmology …
НОВЫЙ ДЕНЬ В МЕДИЦИНЕ
СК ЭГАМОВА - … медицинский институт, ООО" Новый день в … - elibrary.ru
Цитогенетический анализ при остром миелоидном лейкозе (ОМЛ) и остром
лимфобластном лейкозе (ОЛЛ) выявил большое количество неслучайных …
лимфобластном лейкозе (ОЛЛ) выявил большое количество неслучайных …
НОВЫЙ ДЕНЬ В МЕДИЦИНЕ
ЗБ Абдашимов - … медицинский институт, ООО" Новый день в … - elibrary.ru
Вполне очевидно, что практически нет людей, которые бы в течение жизни не
испытывали в той или иной степени ощущение боли, который явилась одной из …
испытывали в той или иной степени ощущение боли, который явилась одной из …
Contact Lenses as Drug Delivery System for Glaucoma: A Review
A Peral Cerdá, A Martínez Águila, C Pastrana… - 2020 - docta.ucm.es
Glaucoma is an optical neuropathy associated to a progressive degeneration of retinal
ganglion cells with visual field loss and is the main cause of irreversible blindness in the …
ganglion cells with visual field loss and is the main cause of irreversible blindness in the …
Role of randomized trials in pharmacoepidemiology
TL Galankin, AS Kolbin - … . Modern Pharmacoeconomics and …, 2015 - pharmacoeconomics.ru
pharmacoepidemiology has recently evolved into a self-dependent post-marketing
disciplinefrom clinical pharmacology, borrowing its methodology and analyticaltools from …
disciplinefrom clinical pharmacology, borrowing its methodology and analyticaltools from …
Frequency of coprescription and potential risk of bronchospasm in colombian patients users of topical antiglaucomatous betablockers and bronchodilators
JE Machado-Alba, V Hoyos-Soto - Vitae, 2014 - revistas.udea.edu.co
Background: Cardiovascular and respiratory effects of adrenergic agonists used in diseases
like chronic obstructive pulmonary disease (COPD), and β-blockers used in glaucoma …
like chronic obstructive pulmonary disease (COPD), and β-blockers used in glaucoma …